On Wednesday, Shares of Stone Energy Corporation (NYSE:SGY), gained 1.99% to $6.66. 3.24 million Shares of the company were exchanged.
The share price of this stock traded recently in a range of $6.24 to $6.80. The company now has a market value of $373.84 million.
Stone Energy Corporation (SGY) declared that the borrowing base under its bank credit facility was reaffirmed at $500 million following its lenders’ scheduled semi-annual redetermination process. There were no other changes to the terms of the credit facility resulting from this borrowing base redetermination. As of October 13, 2015, the credit facility was substantially undrawn with only $19.2 million in letters of credit outstanding.
Stone Energy Corporation, an independent oil and natural gas company, engages in the acquisition, exploration, exploitation, development, and operation of oil and gas properties in the Gulf of Mexico and the Appalachia region.
Shares of Goldman Sachs Group Inc (NYSE:GS), declined -0.89% to $179.36, during its last trading session.
Goldman Sachs (GS) is recognizing YOGASMOGA® founders Rishi Bali (CEO) and Tapasya Bali (COO) as part of the 100 Most Intriguing Entrepreneurs of 2015 at its Builders + Innovators Summit in Santa Barbara, California.
Goldman Sachs selected the YOGASMOGA founders Rishi Bali and Tapasya Bali as among 100 entrepreneurs from multiple industries to be honored at the two-day event. Siblings Rishi and Tapasya Bali bring strong business acumen, attained at Goldman Sachs and Credit Suisse respectively, to their shared passion and deep understanding of yoga.
YOGASMOGA is a yoga-inspired athletic apparel company that upholds the tenets of yoga through responsible and authentic business practices that inspire deep, direct and lasting connections with customers. Founded in 2013 by siblings Rishi and Tapasya Bali, the company is headquartered in New York City with noteworthy production and retail operations in California and Massachusetts.
The Goldman Sachs Group, Inc. operates as an investment banking, securities, and investment administration company worldwide. The company operates through four segments: Investment Banking, Institutional Client Services, Investing & Lending, and Investment Administration.
Finally, Shares of MiMedx Group Inc (NASDAQ:MDXG), ended its last trade with -5.81% loss, and closed at $7.95.
MiMedx Group, Inc. (MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and the Dental sectors of healthcare, declared recently its record revenue results for the third quarter of 2015, its guidance for the fourth quarter of 2015, and that the Company has secured a $50 million Senior Secured Credit Facility.
Third Quarter 2015 Preliminary Highlights are:
- Q3 is 16th successive quarter of meeting or surpassing revenue guidance
- 2015 nine-month revenue of $135.5 million raised by 72% over same period of 2014
- Q3 Revenue of $49 million raised by 46% over Q3 2014
- $49 million revenue is at upper end of $47 to $50 million Q3 guidance range
- The 15thsuccessive quarter of positive Adjusted EBITDA
Guidance Highlights comprise:
- Fourth quarter 2015 revenue expectations of $49.5 - $52.5 million
- Full year 2015 revenue expectations of $185 - $188 million
Revenue Results for Third Quarter and Nine Months Ended September 30, 2015
MiMedx Group, Inc. develops, processes, and markets patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies are AmnioFix, EpiFix, and CollaFix.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
